XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenue
Expenses:        
Cost of sales
Research and development 53,833 83,825 81,076 216,000
Selling, general and administrative 32,253 40,978 111,700 167,534
Total expenses 86,086 124,803 192,776 383,534
Loss from operations (86,086) (124,803) (192,776) (383,534)
Other income (expense)        
Interest income (expense)
Gain on settlement of accounts payable
Net loss $ (86,086) $ (124,803) $ (192,776) $ (383,534)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ 0 $ 0 $ (0.01)
Weighted-average number of common shares outstanding - basic and diluted (in shares) 45,572,568 45,572,568 45,572,568 45,572,568